MIMEDX GROUP INC
For the period ended Dec 31, 2023. Filed Feb 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 28, 2024
MDXG$3.37+1.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations – For the years ended
(in thousands, except share and per share data)
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Net sales | $321,477 | $267,841 | $242,019 |
| Cost of sales | 54,634 | 48,316 | 39,628 |
| Gross profit | 266,843 | 219,525 | 202,391 |
| Operating expenses: | |||
| Selling, general and administrative | 211,124 | 208,673 | 194,846 |
| Research and development | 12,665 | 12,701 | 9,932 |
| Investigation, restatement and related | 5,176 | 12,177 | 3,791 |
| Amortization of intangible assets | 762 | 701 | 820 |
| Impairment of intangible assets | — | — | 53 |
| Operating income (loss) | 37,116 | (14,727) | (7,051) |
| Other expense, net | |||
| Interest expense, net | (6,457) | (5,016) | (4,980) |
| Other expense, net | (26) | (4) | (23) |
| Income (loss) from continuing operations before income tax provision | 30,633 | (19,747) | (12,054) |
| Income tax provision benefit (expense) from continuing operations | 36,806 | (206) | (247) |
| Net income (loss) from continuing operations | 67,439 | (19,953) | (12,301) |
| (Loss) income from discontinued operations, net of tax | (9,211) | (10,244) | 2,016 |
| Net income (loss) | $58,228 | $(30,197) | $(10,285) |
| Net income (loss) from continuing operations available to common stockholders (Note 10) | $55,796 | $(26,533) | $(18,437) |
| Basic net income (loss) per common share: | |||
| Continuing operations | $0.48 | $(0.24) | $(0.17) |
| Discontinued operations | (0.08) | (0.09) | 0.02 |
| Basic net income (loss) per common share: | $0.40 | $(0.33) | $(0.15) |
| Diluted net income (loss) per common share: | |||
| Continuing operations | $0.43 | $(0.24) | $(0.17) |
| Discontinued operations | (0.06) | (0.09) | 0.02 |
| Diluted net income (loss) per common share: | $0.37 | $(0.33) | $(0.15) |
| Weighted average common shares outstanding - basic | 116,495,810 | 112,909,266 | 110,353,406 |
| Weighted average common shares outstanding - diluted | 145,962,462 | 112,909,266 | 110,353,406 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.